CCFP
MRK icon

Charles Carroll Financial Partners’s Merck MRK Stock Holding History

Charles Carroll Financial Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6,406
Closed -$660K – 41
2023
Q3 		$660K Hold
6,406
– – 0.82% 29
2023
Q2 		$739K Buy
6,406
+500
+8% +$56.8K 0.94% 26
2023
Q1 		$628K Buy
5,906
+550
+10% +$59.4K 0.96% 26
2022
Q4 		$594K Buy
5,356
+3
+0.1% +$307 0.92% 28
2022
Q3 		$461K Hold
5,353
– – 0.74% 30
2022
Q2 		$488K Buy
+5,353
New +$475K 0.64% 31

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Charles Carroll Financial Partners's MRK Position: Q4 2023 in Review

Charles Carroll Financial Partners sold out of Merck (MRK) in Q4 2023, closing a stake of 6,406 shares — an estimated $660K sold.

Charles Carroll Financial Partners first reported a position in MRK in Q2 2022 and held it in 6 quarters. The position peaked at $739K in Q2 2023. 3,435 funds tracked by Wall St. Rank hold MRK as of Q4 2023.

  • Charles Carroll Financial Partners reported no remaining Merck position as of Q4 2023 after selling out during the quarter.
  • Charles Carroll Financial Partners sold 6,406 Merck shares in Q4 2023, an estimated $660K.
  • Charles Carroll Financial Partners first reported a position in Merck in Q2 2022 and held it in 6 quarters.
  • Charles Carroll Financial Partners's Merck position peaked at $739K in Q2 2023.
  • 3,435 funds tracked by Wall St. Rank held Merck as of Q4 2023.

Based on Charles Carroll Financial Partners's 13F filing for Q4 2023, filed 6 Feb 2024.